We are live on ! Find out more
TDC

Thompson Davis & Co Portfolio holdings

AUM $150M
1-Year Est. Return 32.35%
This Fund
S&P 500
This Quarter Est. Return
+11.83%
1 Year Est. Return
+32.35%
3 Year Est. Return
+199.51%
5 Year Est. Return
10 Year Est. Return
AUM
$42.2M
AUM Growth
-$14.3M
Cap. Flow
-$17.4M
Cap. Flow %
-41.13%
Top 10 Hldgs %
21.94%
Holding
1,277
New
146
Increased
131
Reduced
218
Closed
593

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$623K
2
INTC icon
Intel
INTC
+$608K
3
BAC icon
Bank of America
BAC
+$558K
4
AAPL icon
Apple
AAPL
+$527K
5
FDC
First Data Corporation
FDC
+$384K

Sector Composition

Rank Sector Weight
1 Technology 18.91%
2 Financials 9.93%
3 Healthcare 9.91%
4 Industrials 9.33%
5 Consumer Discretionary 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOE icon
551
Vanguard Mid-Cap Value ETF
VOE
$23.7B
$4K 0.01%
40
ZTO icon
552
ZTO Express
ZTO
$18.2B
$4K 0.01%
250
SAVE
553
DELISTED
Spirit Airlines, Inc.
SAVE
$4K 0.01%
100
-117
-54% -$4.5K
PRMW
554
DELISTED
Primo Water Corporation
PRMW
$4K 0.01%
225
-275
-55% -$4.42K
SRC
555
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$4K 0.01%
112
AJRD
556
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$4K 0.01%
+125
New +$3.96K
CFMS
557
DELISTED
Conformis, Inc. Common Stock
CFMS
$4K 0.01%
60
+40
+200% +$3.2K
VSLR
558
DELISTED
VIVINT SOLAR, INC.
VSLR
$4K 0.01%
+1,000
New +$3.71K
FSCT
559
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$4K 0.01%
+125
New +$3.35K
SRF
560
DELISTED
THE CUSHING ROYALTY & INCOME FUND
SRF
$4K 0.01%
400
BOLD
561
DELISTED
Audentes Therapeutics, Inc
BOLD
$4K 0.01%
125
-125
-50% -$3.43K
MEET
562
DELISTED
The Meet Group, Inc. Common Stock
MEET
$4K 0.01%
1,500
TEUM
563
DELISTED
Pareteum Corporation
TEUM
$4K 0.01%
+2,000
New +$2.25K
HK
564
DELISTED
Halcon Resources Corporation
HK
$4K 0.01%
+500
New +$3.43K
ADEA icon
565
Adeia
ADEA
$2.86B
$3K 0.01%
+472
New +$2.77K
CBUS icon
566
Cibus
CBUS
$130M
$3K 0.01%
3
COP icon
567
ConocoPhillips
COP
$147B
$3K 0.01%
62
-350
-85% -$18K
CRSP icon
568
CRISPR Therapeutics
CRSP
$4.58B
$3K 0.01%
+125
New +$2.38K
CTMX icon
569
CytomX Therapeutics
CTMX
$705M
$3K 0.01%
+125
New +$2.59K
EIX icon
570
Edison International
EIX
$30.7B
$3K 0.01%
50
FNB icon
571
FNB Corp
FNB
$6.78B
$3K 0.01%
213
GS icon
572
Goldman Sachs
GS
$313B
$3K 0.01%
10
-84
-89% -$20.6K
HES
573
DELISTED
Hess
HES
$3K 0.01%
55
-226
-80% -$10.2K
HOG icon
574
Harley-Davidson
HOG
$2.68B
$3K 0.01%
50
KGC icon
575
Kinross Gold
KGC
$28.5B
$3K 0.01%
617

Similar funds

Thompson Davis & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Thompson Davis & Co held 1,277 positions worth $42.2M, down 25% from $56.5M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Thompson Davis & Co withdrew a net $17.4M in Q4 2017, closing 593 positions and reducing 218 holdings. Its most notable exit was Antares Pharma, Inc., an estimated $365K position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Thompson Davis & Co opened a new position in General Motors worth $241K.

  • Thompson Davis & Co's largest Q4 2017 buy was General Motors: 5,878 shares worth $241K.
  • Thompson Davis & Co added most to Vanguard Small-Cap Value ETF in Q4 2017, an estimated $601K increase.
  • Thompson Davis & Co's biggest Q4 2017 reduction was JPMorgan Chase, cutting an estimated $623K.
  • Thompson Davis & Co fully exited Antares Pharma, Inc. in Q4 2017, selling an estimated $365K.
  • Thompson Davis & Co's ten largest holdings make up 22% of its $42.2M portfolio in Q4 2017.
  • Thompson Davis & Co opened 146 new positions and closed 593 in Q4 2017.
  • Thompson Davis & Co's portfolio value fell 25% quarter-over-quarter to $42.2M.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.